Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of vemurafenib in hairy-cell leukemia.

The New England journal of medicine - 16 Jan 2014

Samuel Jesvin, Macip Salvador, Dyer Martin J S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Indoles
Share to Leukemia, Hairy Cell
Share to Mutation
Share to Phosphorylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Share to Sulfonamides

Share to Vemurafenib

Source

Identifiers

PMID: 24428489
DOI: 10.1056/NEJMc1310849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of vemurafenib in hairy-cell leukemia.PMID 24428489Read ↗

Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation.Semantic proximity Read ↗

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.Semantic proximity Read ↗

BRAF inhibition in refractory hairy-cell leukemia.Semantic proximity Read ↗

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.Semantic proximity Read ↗

BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activitySemantic proximity Read ↗

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.Semantic proximity Read ↗

Hairy cell leukemia: update and current therapeutic approach.Semantic proximity Read ↗

Non-V600E BRAF mutations and treatment for hairy cell leukemia.Semantic proximity Read ↗

Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.Semantic proximity Read ↗

Genomics of Hairy Cell LeukemiaSemantic proximity Read ↗

[Molecular and therapeutic advances in Hairy cell leukemia].Semantic proximity Read ↗

Hairy cell leukemia: Past, present and future.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.